CEL-SCI Corporation (CVM) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

CEL-SCI Corporation (CVM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $9.7M, listed on AMEX, employing roughly 43 people, carrying a beta of 0.71 to the broader market. CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. Led by Geert R. Kersten, public since 1983-12-08.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for CVM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →